Urology Medical News about PSA

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Effect of Body Mass Index and Waist Circumference on Prostate Specific Antigen and Prostate Volume in a Generally Healthy Korean Population
The Journal of Urology, 06/17/09

Park JH et al. - Obesity had a negative association with prostate specific antigen regardless of prostate volume, and a positive association with prostate volume. Age was not associated with prostate specific antigen after prostate volume adjustment. Obese men, especially those with a small prostate volume, may have lower baseline prostate specific antigen and, thus, be at higher risk for having prostate cancer undetected in a prostate specific antigen screening test.

<< Previous
Emergence of Extended-Spectrum beta-Lactamase–Producing...

Next >>
Urinary nerve growth factor level is increased in patients with...

Prostatic specific antigen for prostate cancer detection
International Braz J Urol, 10/30/09 Relevance Score: 97%

Hepatoprotective effect of TNF-alpha blockade in psoriatic arthritis: A cross-sectional study
Annals of Rheumatic Diseases, 11/16/09 Relevance Score: 92%

Relationship Between Prostate-specific Antigen and Hematocrit: Does Hemodilution Lead to Lower PSA Concentrations in Men With a Higher Body Mass Index
Urology, 10/28/09 Relevance Score: 89%

Early PSA decrease is an independent predictive factor of clinical failure and specific survival in patients with localized prostate cancer treated by radiotherapy with or without androgen deprivation therapy
Annals of Oncology, 10/16/09 Relevance Score: 89%

PSA at postoperative three months can predict biochemical recurrence in patients with pathological T3 prostate cancer following radical prostatectomy
International Journal of Urology, 10/15/09 Relevance Score: 89%